End-user global study to identify countries’ challenges and solutions in the uptake and implementation of new tuberculosis treatment regimens

<title>Extract</title> We read with interest the study by B<sc>éranger</sc> <italic>et al</italic>. [1] and the related editorial [2], which raised once more the issue of improving existing anti-tuberculosis (TB) regimens.